Valion Bio, Inc. Ttl Offering Amt
Valion Bio, Inc. (VBIO) had Ttl Offering Amt of $30.99 million as of 2026-07-13, per its S-1 filed 2026-07-17.
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-07-17
- 2026-07-13: Ttl Offering Amt $30.99M.
- 2026-04-11: Ttl Offering Amt $946.66K.
| Period end | Ttl Offering Amt |
|---|---|
| 2026-07-13 | $30.99M S-1 · filed 2026-07-17 |
| 2026-04-11 | $946.66K S-1 · filed 2026-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |